Literature DB >> 8027586

Up-regulation of elafin/SKALP gene expression in psoriatic epidermis.

K Nonomura1, K Yamanishi, H Yasuno, K Nara, S Hirose.   

Abstract

The expression of mRNA for elafin/SKALP, an inhibitor of leukocyte elastase and proteinase 3, in human normal and psoriatic epidermis was examined by in situ hybridization. In normal epidermis, elafin/SKALP mRNA was detected in the granular layer, but not in the spinous or basal layers. In fully developed psoriatic lesions, elafin/SKALP mRNA was found in the suprabasal layers of the ridges, and in the upper two thirds of the stratum malpighii at the elongated rete ridges. Intense staining was noted near the subcorneal microabscess in psoriasis vulgaris and under the subcorneal pustule in localized pustular psoriasis. In the marginal psoriatic epidermis, elafin/SKALP mRNA was expressed from the middle or upper spinous layer to the subcorneal layer, and the cells expressing elafin/SKALP mRNA increased especially under the parakeratotic corneal layer intermingled with pyknotic nuclei of neutrophils. These findings suggest that the induction of elafin/SKALP gene expression is related closely to the infiltration of neutrophils into the epidermis in psoriasis and plays an important role in protecting the skin components against the tissue damage caused by the infiltrated leukocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027586     DOI: 10.1111/1523-1747.ep12391802

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin.

Authors:  Johann E Gudjonsson; Jun Ding; Xing Li; Rajan P Nair; Trilokraj Tejasvi; Zhaohui S Qin; Debashis Ghosh; Abhishek Aphale; Deborah L Gumucio; John J Voorhees; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2009-07-02       Impact factor: 8.551

Review 2.  Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease.

Authors:  Brenda J Curtis; Katherine A Radek
Journal:  J Invest Dermatol       Date:  2011-09-15       Impact factor: 8.551

Review 3.  The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core.

Authors:  J Schalkwijk; O Wiedow; S Hirose
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

4.  Elafin is a biomarker of graft-versus-host disease of the skin.

Authors:  Sophie Paczesny; Thomas M Braun; John E Levine; Jason Hogan; Jeffrey Crawford; Bryan Coffing; Stephen Olsen; Sung W Choi; Hong Wang; Vitor Faca; Sharon Pitteri; Qing Zhang; Alice Chin; Carrie Kitko; Shin Mineishi; Gregory Yanik; Edward Peres; David Hanauer; Ying Wang; Pavan Reddy; Samir Hanash; James L M Ferrara
Journal:  Sci Transl Med       Date:  2010-01-06       Impact factor: 17.956

Review 5.  The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.

Authors:  Alaa M Ali; John F DiPersio; Mark A Schroeder
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-05       Impact factor: 5.742

6.  Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia.

Authors:  R Pfundt; F van Ruissen; I M van Vlijmen-Willems; H A Alkemade; P L Zeeuwen; P H Jap; H Dijkman; J Fransen; H Croes; P E van Erp; J Schalkwijk
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 7.  Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  Br J Pharmacol       Date:  2009-10       Impact factor: 8.739

8.  Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.

Authors:  Nicolas Guyot; Marcus W Butler; Paul McNally; Sinead Weldon; Catherine M Greene; Rodney L Levine; Shane J O'Neill; Clifford C Taggart; Noel G McElvaney
Journal:  J Biol Chem       Date:  2008-09-17       Impact factor: 5.157

Review 9.  Antimicrobial peptides in human skin disease.

Authors:  Kenshi Yamasaki; Richard L Gallo
Journal:  Eur J Dermatol       Date:  2007-12-18       Impact factor: 3.328

10.  Humanized mouse model of skin inflammation is characterized by disturbed keratinocyte differentiation and influx of IL-17A producing T cells.

Authors:  Vivian L de Oliveira; Romy R M C Keijsers; Peter C M van de Kerkhof; Marieke M B Seyger; Esther Fasse; Lars Svensson; Markus Latta; Hanne Norsgaard; Tord Labuda; Pieter Hupkens; Piet E J van Erp; Irma Joosten; Hans J P M Koenen
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.